Investors

Now firmly established in London’s premier biopharma & medtech partnering week, this is where capital meets innovation, and global leaders come to connect, pitch, and partner.

The event will bring together C-Suite executives from leading public and private companies from around the globe and across diverse healthcare sub-sectors. In 2024, we hosted over 700 healthcare companies, 3,600 attendees, and 10,000 investor and business-to-business meetings. New for 2025, Monday, November 17 will mark the launch of a focused Biotech/Biopharma Kick-off Day, while […]

RESI London and Gensis are combining to offer a multi-day investment, partnering and thought leadership event for venture stage companies seeking funding and strategic alliances.

The RESI Conference will be held on January 12-13 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 14, 19&20) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 500 early-stage life science investors, innovators, and industry experts. This RESI […]

Leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives, providing a platform to showcase their innovations and facilitate one-on-one meetings.

BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.

This premier conference is the largest and most informative healthcare investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

The pharma and biotech industries stand at an inflection point unseen since the genomic revolution. After years of pandemic-fueled growth and subsequent market turmoil, companies are redefining how they will survive and thrive. Capital is scarcer. Regulators worldwide are rewriting the rules. Breakthrough therapies in oncology, rare diseases and obesity are upending competition, even as […]

Exploring how disease foundations and social venture funds are accelerating the commercialization of early-stage technologies and therapies. Invest in Cures 2026 - A Disease Foundation Forum Join us on February 12, 2026 at the University of California San Francisco (UCSF) to explore the transformative potential of impact investing in addressing rare disease challenges. This annual […]

Our exclusive partnering and investor forum brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech, and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and […]

The BIO Investment & Growth Summit is the new event organized by BIO, the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Join us in Miami Beach for two impactful days as we address the […]